10–20% weight loss possible
BIG-registered doctors
Delivered chilled & discreetly
Fully online support
Wegovy injection pen
Weekly treatment

Wegovy

Semaglutide · once a week

Trustpilot
From
€425 per month
depending on the dosage and stage of treatment

Wegovy is a prescription treatment containing semaglutide for weight management. The medicine can reduce appetite and increase the feeling of fullness. The doctor will always assess first whether treatment is medically appropriate.

Use Once a week
Research findings Average ±15%
Active substance Semaglutide

That’s why you choose WeightConsult

Assessment by BIG-registered doctors
Medical support throughout the process
Arranged online and discreetly
A treatment plan tailored to your situation
Check if you’re eligible → View rates

The BMI check provides an initial indication. A doctor will ultimately decide whether treatment is appropriate.

What is Wegovy?

Semaglutide may reduce appetite and food intake

Wegovy contains semaglutide, a substance that mimics the action of GLP-1. This hormonal signal plays a role in appetite, satiety and the body’s response to food.

As a result, some people may feel less hungry and feel full sooner. This can make it easier to consistently consume fewer calories.

1

Loss of appetite

Semaglutide affects signals in the brain that are involved in hunger and food intake.

2

Filled up earlier

Feeling fuller for longer or more intensely can help you eat smaller portions.

3

Support with weight loss

If energy intake falls on a sustained basis, body weight may decrease.

Use and structure

Wegovy is being built up step by step

Wegovy is injected once a week. The official dosage regimen starts low and is then gradually increased, to allow the body time to get used to semaglutide.

Step 10.25 mgInitial dose
Step 20.5 mgContinued
Step 31.0 mgFurther development
Step 41.7 mgFurther development
Maintenance2.4 mgUsual maintenance dose

The dosage and rate of increase are tailored to the treatment plan. This is general product information and does not constitute personalised dosage advice.

Average weight loss in the study±15%of the original body weight*

Result

What can you expect from Wegovy?

In a large clinical trial with semaglutide 2.4 mg, the average 14.91 TP3T weight loss ... as mentioned. Nutrition, exercise and lifestyle guidance were all part of the treatment.

Loss of appetiteGreater satietySupport with weight loss

* Average study results do not guarantee individual outcomes.

Side effects and safety

What are the common side effects?

Wegovy is most commonly associated with gastrointestinal symptoms, particularly during the build-up phase.

Common complaints

The official product information lists, amongst other things, nausea, diarrhoea, vomiting, constipation and abdominal pain.

NauseaDiarrhoeaVomitingObstipation

That is why we carry out an assessment in advance

Wegovy is available on prescription only and is not suitable for everyone. Your doctor will therefore assess your medical history, other medication and any relevant risks before starting treatment.

Cost

How much does treatment with Wegovy cost?

The price changes as the dosage is increased during the course of treatment. That is why we keep the full, up-to-date price structure centralised on our rates page.

Current ratesView overview

View the current price per dose and per month of treatment.

View Wegovy rates →

How WeightConsult works

From the initial check-up to ongoing support

You don’t need to decide in advance which treatment is best for you. The doctor will assess what is medically appropriate.

1

BMI check

Initial indication.

2

Medical assessment

Health and medication.

3

Doctor’s appointment + consultation

Assessment and treatment plan.

4

Getting started + support

The chemist’s and what happened next.

Frequently asked questions

Short answers to questions about Wegovy

Yes. Wegovy is authorised in Europe for weight management in people who meet the medical criteria, in combination with a calorie-restricted diet and increased physical activity.

In STEP 1, an average weight loss of 14.9% was observed with semaglutide 2.4 mg. Individual results may vary.

Both contain semaglutide. Wegovy is specifically authorised for weight management and has its own dosing regimen for this purpose; Ozempic is authorised for type 2 diabetes.

Wegovy is administered subcutaneously once a week, with the dose increased gradually.

Yes. Wegovy is available on prescription only and is only prescribed when the doctor considers treatment to be medically justified.

Ready to take the next step?

Check whether a treatment is right for you

You now know how the fees are structured and what treatment options are available. So the next step is simple: start with the BMI check and find out whether you might be able to proceed to the medical assessment.

Initial assessment via a BMI check Medical assessment remains the guiding principle Handled entirely online
Check whether you are eligible Compare treatment options

A positive BMI check does not constitute medical approval.